Assisted reproductive technology and ovarian cancer

被引:1
|
作者
Devesa, M. [1 ]
Barri, P. N. [1 ]
Coroleu, B. [1 ]
机构
[1] Inst Univ Dexeus, Serv Reprod Med, Dept Obstet Gynecol & Reprod, Barcelona 08028, Spain
关键词
Ovarian neoplasms; Infertility; Fertility agents; Ovulation induction; IN-VITRO FERTILIZATION; ORAL-CONTRACEPTIVE USE; TERM-FOLLOW-UP; FERTILITY DRUGS; OVULATION INDUCTION; INFERTILE WOMEN; RISK; STIMULATION; COHORT; BREAST;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ovarian cancer has the highest mortality among all gynaecological cancers, being multiparity and oral contraceptive use the most important protective factors. According to both the "incessant ovulation" and "increased gonadotrophin" theories, fertility drugs might hive an association with the development of ovarian cancer, as has been reported by some studies. However, infertility and nulliparity may act as confounding factors and most studies regarding this issue are hampered by methodological limitations. It seems that female infertility may be associated with a modest increase in ovarian cancer risk in those patients who remain nulligravid despite long periods of unprotected intercourse. Globally, most studies are reassuring in not showing a link between the use of fertility drugs and an increased risk of ovarian cancer. Nonetheless, further research in well-designed studies is warranted.
引用
收藏
页码:247 / 257
页数:11
相关论文
共 50 条
  • [31] Biological versus chronological ovarian age: implications for assisted reproductive technology
    Carlo Alviggi
    Peter Humaidan
    Colin M Howles
    Donald Tredway
    Stephen G Hillier
    Reproductive Biology and Endocrinology, 7
  • [32] Risk of Preeclampsia in Pregnancies After Assisted Reproductive Technology and Ovarian Stimulation
    Martin, Angela S.
    Monsour, Michael
    Kawwass, Jennifer F.
    Boulet, Sheree L.
    Kissin, Dmitry M.
    Jamieson, Denise J.
    MATERNAL AND CHILD HEALTH JOURNAL, 2016, 20 (10) : 2050 - 2056
  • [33] ETHNIC DIFFERENCES IN OVARIAN RESERVE AND ASSISTED REPRODUCTIVE TECHNOLOGY OUTCOMES.
    Jayakumaran, J.
    Silva, C.
    Gangrade, B. K.
    Patel, S.
    FERTILITY AND STERILITY, 2016, 106 (03) : E368 - E369
  • [34] Access to assisted reproductive technology for cancer patients in Australia
    Mcconnell, Ryan
    Stankiewicz, Marcin
    Koczwara, Bogda
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (02) : 123 - 128
  • [35] Assisted reproductive technology treatment and risk of breast cancer
    Vassard, D.
    Pinborg, A.
    Kamper-Jorgensen, M.
    Forman, J. Lyng
    Glazer, C. H.
    Kroman, N.
    Schmidt, L.
    HUMAN REPRODUCTION, 2019, 34 : 16 - 17
  • [36] Risk of Cancer in Children Conceived by Assisted Reproductive Technology
    Reigstad, Marte Myhre
    Larsen, Inger Kristin
    Myklebust, Tor Age
    Robsahm, Trude Eid
    Oldereid, Nan Birgitte
    Brinton, Louise A.
    Storeng, Ritsa
    PEDIATRICS, 2016, 137 (03)
  • [37] Assisted reproductive technology and association with childhood cancer subtypes
    Gulrajani, Natalie B.
    Montes, Samuel
    McGough, Daniel
    Wimberly, Courtney E.
    Khattab, Ameera
    Semmes, Eleanor C.
    Towry, Lisa
    Cohen, Jennifer L.
    Hurst, Jillian H.
    Landi, Daniel
    Hill, Sherika N.
    Walsh, Kyle M.
    CANCER MEDICINE, 2023, 12 (03): : 3410 - 3418
  • [38] ASSISTED REPRODUCTIVE TECHNOLOGY & RISK OF CHILDHOOD CANCER.
    Spector, L. G.
    Luke, B.
    Wantman, E.
    Schymura, M. J.
    Brown, M. B.
    FERTILITY AND STERILITY, 2013, 100 (03) : S165 - S165
  • [39] CANCER IN WOMEN AFTER ASSISTED REPRODUCTIVE TECHNOLOGY.
    Luke, B.
    Brown, M. B.
    Spector, L. G.
    Missmer, S. A.
    Leach, R.
    Williams, M.
    Koch, L.
    Smith, Y.
    Stern, J. E.
    Ball, G. D.
    Schymura, M. J.
    FERTILITY AND STERILITY, 2014, 102 (03) : E52 - E53
  • [40] Is Assisted Reproductive Technology Associated with Increased Risk of Cancer?
    E Williams
    D Ratnaraj
    H Holme
    Pediatric Research, 2011, 70 : 360 - 360